ok maybe cap raise not so soon as will still have $10m left come dec quarter. Still with $174m fully diluted market value plenty of revenue and profits built in.
- Forums
- ASX - By Stock
- ISN
- chart
chart , page-14
-
- There are more pages in this discussion • 109 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add ISN (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online